KMWM
JAZZ icon

Keudell/Morrison Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Hold
1,359
– – 0.06% 183
2026
Q1 		$257K Hold
1,359
– – 0.05% 198
2025
Q4 		$231K Buy
+1,359
New +$208K 0.05% 209
2023
Q1 		– Sell
-1,359
Closed -$217K – 190
2022
Q4 		$217K Buy
+1,359
New +$199K 0.07% 176

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Keudell/Morrison Wealth Management's JAZZ Position: Q2 2026 in Review

Keudell/Morrison Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 1,359 shares worth $327K. The position accounts for 0.06% of the portfolio, ranked #183.

Keudell/Morrison Wealth Management first reported a position in JAZZ in Q4 2022 and has held it in 4 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Keudell/Morrison Wealth Management held 1,359 shares of Jazz Pharmaceuticals worth $327K as of Q2 2026.
  • Keudell/Morrison Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.06% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #183 holding.
  • Keudell/Morrison Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 4 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.